Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The inhibition of glycolysis in tumor cells by methionine requires that the cells be incubated with methionine for several hours in the presence of serum. We now show that in the case of confluent rat-1 fibroblasts transfected with the ras gene the serum can be substituted by insulin and insulin-like growth factor I or II. No other growth factor tested was effective. In subconfluent ras cells additional growth factors (transferrin and high density lipoproteins) were required for maximal inhibition of glycolysis by methionine. Exploration of the mechanism of action of methionine revealed that the accumulation of [35S]methionine into rat-1 fibroblasts was only marginally increased by insulin. We propose that methionine inhibits an
adenosine triphosphatase
activity because addition of low concentrations of Nonidet P-40 greatly enhanced glycolysis even in the presence of methionine, suggesting that it did not affect the glycolytic enzymes directly.
Methionine
also affected growth both in monolayer and soft agar. Rat-1 fibroblasts transfected with the ras gene were markedly more sensitive to methionine than cells transfected with the myc gene.
...
PMID:Effect of growth factors and methionine on glycolysis and methionine transport in rat fibroblasts and fibroblasts transfected with myc and ras genes. 308 Dec 58
The crystal structure of the high-affinity Escherichia coli MetNI methionine uptake transporter, a member of the adenosine triphosphate (ATP)-binding cassette (ABC) family, has been solved to 3.7 angstrom resolution. The overall architecture of MetNI reveals two copies of the
adenosine triphosphatase
(
ATPase
) MetN in complex with two copies of the transmembrane domain MetI, with the transporter adopting an inward-facing conformation exhibiting widely separated nucleotide binding domains. Each MetI subunit is organized around a core of five transmembrane helices that correspond to a subset of the helices observed in the larger membrane-spanning subunits of the molybdate (ModBC) and maltose (MalFGK) ABC transporters. In addition to the conserved nucleotide binding domain of the ABC family, MetN contains a carboxyl-terminal extension with a ferredoxin-like fold previously assigned to a conserved family of regulatory ligand-binding domains. These domains separate the nucleotide binding domains and would interfere with their association required for ATP binding and hydrolysis.
Methionine
binds to the dimerized carboxyl-terminal domain and is shown to inhibit
ATPase
activity. These observations are consistent with an allosteric regulatory mechanism operating at the level of transport activity, where increased intracellular levels of the transported ligand stabilize an inward-facing,
ATPase
-inactive state of MetNI to inhibit further ligand translocation into the cell.
...
PMID:The high-affinity E. coli methionine ABC transporter: structure and allosteric regulation. 1862 68